What we choose to call cancer may shape patients’ behavior in ways that influence their health outcomes. Relabeling low-grade ...
NCI Researcher Presents Research on the Role of White Blood Cells in Bone Metastatic Prostate Cancer
The Georgetown University Lombardi Comprehensive Cancer Center held a lecture on how certain white blood cells in the immune system can contribute to bone metastatic prostate cancer as part of their ...
You're invited to a free special presentation by Christus St. Vincent Regional Medical in Santa Fe centering on Prostate Health and Prostate Cancer. The lecture will be held on santafenewmexican.com ...
Winthrop-University Hospital's Clinical Trials Center in Mineola is seeking volunteers with polymyalgia rheumatica (PMR) to participate in a clinical research study of a medication currently used to ...
SurvivorNet on MSN
ASCO 2026: A major prostate cancer trial shows drug can keep high-risk disease from returning for longer
Data from the PROTEUS trial showed that adding a hormone-blocking pill called apalutamide to standard hormone therapy, both ...
Results of a multicenter clinical trial found that adding the investigational adenoviral-based viral immunotherapy ...
Set for today, “How to Understand Your PSA Test Results” is the first of several free public talks on cancer from the Cancer Therapy & Research Center at the UT Health Science Center-San Antonio. CTRC ...
If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.
But despite this good news, the overall number of new prostate cancer cases and deaths is on the rise in the U.S.: 2014: 182,806 new prostate cancer cases 2019: 224,733 new prostate cancer cases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results